MDRZYMES · Multidrug resistance gene regulators as scaffolds for the design and evolution of artificial metalloenzymes
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2017-03-01 → 2019-02-28
- Финансиране от ЕС
- 165 599 €
- Участници
- 1
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Протеини, регулиращи устойчивостта към лекарства, се използват за създаване на изкуствени ензими чрез добавяне на метални комплекси и необичайни аминокиселини. Това помага за разработването на екологични методи за химичен синтез и откриването на нови начини за оптимизиране на биокатализаторите.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Multidrug resistance gene regulators as scaffolds for the design and evolution of artificial metalloenzymes
Enzymes are remarkable catalysts and the prospects of harnessing their catalytic power in industrial settings have fueled efforts to tailor biocatalysts for synthetic purposes. Indeed, mimicking the Darwinian algorithm in the laboratory, often referred to as directed evolution, has allowed for rapidly boosting the performance of existing enzymes. But what about transformations that are desirable for synthesis, yet for which no enzymes exist in nature? Creating such designer enzymes is a formidable challenge and of particular interest to chemists and biologists alike. For the former, made-to-order biocatalysts could offer a ‘green’ alternative to existing synthetic routes while for the latter creating and improving enzymes with new-to-nature activities could provide the unique opportunity to identify enzyme optimization strategies not yet explored by nature. For the creation of designer enzymes, multidrug resistance gene regulators (MDRs) are an intriguing class of proteins. In nature, these dimeric proteins serve as binding hubs for a diverse set of adversary molecules, such as antibiotics or polyaromatic compounds. Taking advantage of their remarkably promiscuous binding abilities, the Roelfes group were the first to highlight the potential of MDRs for enzyme design. Specifically, they demonstrated that the binding of planar, aromatic transition metal complexes in these binding pockets resulted in the creation of efficient hybrid enzymes for a number of abiological reactions. In an effort to expand the catalytic repertoire and improve these novel reactivities by directed evolution techniques, we incorporated unnatural amino acids featuring uniquely reactive functional groups in the hydrophobic pore of LmrR, an MDR found in Lactococcus lactis. By genetically incorporating an aniline side chain, we identified a designer enzyme, LmrR_V15pAF, that was able to catalyze a model hydrazone formation with rate accelerations orders of magnitude higher than aniline in solution. In another line of research, we evaluated the performance of various palladium complexes for cross coupling reactions inside the binding pockets of MDRs, yet failed to identify catalytically active hybrid catalysts.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Enzymes are remarkable catalysts. The unmatched rate accelerations and exacting selectivities that these protein molecules achieve have whetted the appetite of chemists to harness the prowess of enzyme catalysis for industrial applications. However, natural enzymes can only catalyze a small fraction of the reactions routinely employed by synthetic chemists. As a result, creating designer biocatalysts with the ability to efficiently catalyze transformations not found in nature’s repertoire is a long-standing goal in chemical biology. To meet this challenge, this proposal describes our plans to generate proficient enzymes for palladium-catalyzed cross-coupling reactions. Specifically, we will create hybrid catalysts by recruiting active palladium complexes to the promiscuous binding sites of multidrug resistance gene regulators. We will validate productive assemblies by a rigorous biophysical characterization and evaluate the resulting artificial metalloenzymes for their ability to catalyze model Suzuki-Miyaura cross-coupling reactions. To refine the activities and selectivities of these primitive catalysts we will explore directed evolution protocols to identify mutations in the protein scaffolds that are beneficial for catalysis. In one strategy, we will establish a fluorescence-based screening approach that allows for testing libraries of hybrid catalysts in multi-well format. Another strategy will evaluate the possibility of performing cross-coupling reaction in vivo. Toward this end, artificial metalloenzymes will be assembled in the periplasm and utilized for the synthesis of a non-standard amino acid, which subsequently can be incorporated into a selection marker. As a result, bacteria producing improved variants will outgrow those with less efficient catalysts under selection conditions. Overall, our efforts will generate proficient designer enzymes that could prove valuable for applications in sustainable chemical processes.
Оригинален текст от CORDIS (на английски).
Участници
- RIJKSUNIVERSITEIT GRONINGEN · GroningenКоординаторНидерландия
Връзки
Данни: CORDIS, © Европейски съюз
